LONDON (AFX) - Provexis PLC said it has entered into a long-term collaboration agreement with Unilever PLC to jointly develop a new concentrated format of its patented Fruitflow heart-health technology for application in Unilever's food product portfolio.

Financial details of the deal were not disclosed.

The partners plan to enter into a global licence arrangement for the technology.

Fruitflow is a patented natural extract from tomato which Provexis said has been shown in human trials to reduce the propensity for aberrant blood clotting that is typically associated with cardiovascular disease and which can lead to heart attack or stroke.

In 2005 the market for heart benefit foods was worth 4 bln usd globally, Provexis added.

Considering the growth potential this share has a target of about 8-10p in the medium tern and is a good buy at current levels

As usual, pls do ur own research.

So an extra ten bob then! lol

cynic
it was just a suggestion.as for it being too late i must suppose our posts crossed in those intervening minutes, it happens. no need for the hail Marys,
regards to you.
jkd

PXS gone above 8p now!

rabbi asked, "What are those?" ...... Beloved is worth at least 2 goats or 1 camel, and they now cost more than 50p each thanks to rampant inflation.

You should be careful Cynic - your wife may wish to put you up for sale when she finds out how much you're worth, after all the profits you've been raking in over the past few days!

can't be worth much ... too old to be put to stud and news of the vasectomy wouldn't be much of a selling point either!

given the recent strength of PXS, i find the following announcement very interesting ....


ANGLE plc ('ANGLE') is pleased to announce that in line with its declared strategy it has completed the disposal of its remaining holding in its mature portfolio company Provexis Plc ('Provexis').
At 30 April 2009, ANGLE's holding in Provexis was held on the balance sheet at a fair value of 0.5m. This has been sold at a profit of 0.9m generating 1.4m in cash.
The disposal of this holding significantly strengthens ANGLE's cash position and reinforces ANGLE's established strategy to focus its efforts and resources on the winners within its portfolio.

Andrew Newland, Chief Executive of ANGLE plc said:
'Completion of this realisation puts ANGLE is a strong position to progress its principal holdings including Novocellus (in vitro fertilisation - 82% holding), Geomerics (Enhanced computer games middleware - 47% holding) and Parsortix (Prenatal diagnostics - 76% holding).'


what % did they hold on 30th April?

Was it 20%?

on 30th april 09 the sp was less tha 1p, however they say the shareholding was held in their balance sheet at "fair value".They only made a profit of 900k so if they sold recently then the book cost must have been much higher than the sp on 30/4/09.

RNS dated 2/7/09 says they held 5.2%... 42m shares

they sold most of the shares at and around a penny if i remember right.

that perhaps explains the slightly waspish comment in the rns

Finished 8.07p happy with that. I say again looks good for tmrw!

cynic angle appear to have sold out at 3.3p their CEO must be feeling really clever having missed the boat after so long.

I know that Angle were a bit strapped for cash, but I'll bet there will be a bit of kicking going on in the office! :o)

i bet the management at PXS are pissing themselves laughing too

Tail wagging the dog or tail wagging a dog................?!

angle started with nearer 65m shares...... would have made deal when the decided to dispose and price seems to have started rising soon after - poor timing but they made a big profit on their initial investment which must have looked really good at the time of deal following 12-18 months languishing at circa 1p. If any of us had been offered 2 or 3p a share during that time we may also have jumped..

Wow another good start today! Are we going to see 10p today?

tell me children, clearly the sky is NOT the limit, so is there a realistic short-term target in mind?